BiotechTube
Home/Hetero/Dr. Prashant S. Singh
DP

Dr. Prashant S. Singh

MD & CEO

Hetero

Therapeutic Areas

Infectious DiseasesVirologyAntiretroviralBiosimilars

Hetero Pipeline

DrugIndicationPhase
Movfor (Molnupiravir)COVID‑19Phase 3
Nirmatrelvir/Ritonavir GenericCOVID‑19Commercial
Tenofovir Disoproxil FumarateHIVCommercial
Trastuzumab BiosimilarHER2‑positive Breast CancerPhase 3

Leadership Team at Hetero

DR
Dr. R. K. Mishra
Chief Scientific Officer
View full Hetero profile